2026 Kiin Pioneer Programme
For Academics & Non-profit research teams wanting to scale their science by connecting all scientific insights
Scientific discovery rarely fails because researchers lack insight.
It stalls when promising ideas, large datasets, and critical decisions become disconnected.
The Kiin Pioneer Programme is a one-year programme for selected academic and nonprofit research teams working on life science, early discovery, translational biology, and therapeutic research.
It is designed for scientists who want to move fast and make better decisions across complex research workflows: which targets to prioritise, which hypotheses to test, which datasets to trust, and which experiments should come next.
Selected teams receive access to our KiinOS platform, scientific support from the Kiin Bio science team, and technical support.
Why This Programme Exists
Research teams are generating more data than ever before, but scientific discovery often stalls at the point of hypothesis-generation and decision-making.
Promising early findings are often spread across papers, datasets, internal notes, and expert judgment. Priorities can be hard to compare, hypotheses difficult to track, and promising signals slow to translate into action.
This programme is designed for teams who want to make their discovery process faster, more systematic, transparent, and actionable.
We are especially interested in teams working on questions such as:
Which targets should we prioritise, and why?
Which hypotheses are worth testing next?
How should we interpret conflicting evidence across datasets?
Where are the strongest translational opportunities?
How can we make complex scientific decisions easier to track, explain, and revisit?
What Selected Teams Receive
Each selected team receives:
One year of access to KiinOS
Regular check-ins with the Kiin Bio science team
Structured onboarding to help the team map their research workflow into the platform
Platform support throughout the programme
Support high-value use cases, such as target prioritisation, hypothesis generation, biomarker discovery and data analysis, disease area mapping, or cross-dataset interpretation
Opportunities for visibility through our newsletter and community (Kiin Bio Weekly) with case studies, interviews, or joint thought leadership where appropriate
Access to a broader network of researchers, founders, and operators working across AI and drug discovery
The goal is not simply to provide software access. It is to help the best teams to apply KiinOS to real scientific use cases inside their existing research workflows.
Example Use Cases
The programme is designed for research teams working on early discovery and translational research challenges, including:
Target identification and prioritisation
Small molecule discovery strategy
Biomarker discovery
Disease area exploration
Cross-dataset analysis & interpretation
Evidence mapping across publications, datasets, and internal findings
Translational decision-making between discovery and downstream validation
Who Should Apply
We are looking for research teams and scientists in academia or nonprofit organisations who:
Are working on early discovery, translational biology, or therapeutic research
Are frustrated that their research is not moving fast enough
Have a clearly defined scientific problem or decision bottleneck
Want to make their research workflow faster, more systematic and decision-oriented
Are working with complex evidence across datasets, literature, experiments, or disease areas
What This Programme Is Not
This programme is Not:
A funding grant or stipend
A general AI training course
A replacement for lab infrastructure
A data-generation service
A programme for large-scale raw data ingestion without a defined scientific question
A fit for projects requiring patient-level sensitive data
Part of a Broader Conversation
The Academic & Nonprofit Programme sits within a wider ecosystem we host through Kiin Bio Weekly, a curated publication read by nearly 1,000 researchers, founders, industry operators, and life sciences investors working across AI and drug discovery.
Each week, we share:
Focused round-ups of emerging tools, models, and datasets shaping the field
Interviews with the scientists and founders building them
Occasional primers and explainers that unpack complex topics, from protein language models to structural biology, and break down major field-wide challenges and competitions shaping where the community is heading
Selected teams operate within this broader signal network, not just within a single platform.
Explore Kiin Bio Weekly → https://newsletter.kiin.bio/
Data & Institutional Considerations
The programme is intentionally lightweight:
No patient-level or clinical data required
No large proprietary data transfer required
We do not train on your data
ISO 27001 compliant infrastructure
All IP remains with your institution
In most cases, no complex procurement process is required.
Timeline
Applications Open: May 2026
Deadline: August 2026
Cohort Announced: September 2026
Programme Start: September 2026
Frequently Asked Questions
Do we need to transfer sensitive data? No.
Is there a stipend? No. This programme provides platform access and scientific and technical support.
Who owns the IP? Your institution retains all IP.
Can multiple members of our lab participate? Yes. We welcome full lab applications.
Is this only for academic institutions? No. Nonprofit research organisations working on discovery and translational research are also eligible.
If your research generates insight but you want stronger connection and velocity between data and decision, this programme is designed for you.